Clinical Trial Applications - Approved: Filter, Search, and view applications


Clear
Extended search...

Page 39 of 58, showing 10 Applications out of 576 total, starting on record 381, ending on 390

# Protocol No Study Title Investigator(s) & Site(s) Date Approved

381.

ECCT/19/05/01   A randomized, double-blinded, placebo-controlled, dose-escalation phase 1 clinical trial to evaluate the safety and immunogenicity of recombinant HIV envelope protein BG505 SOSIP.664 gp140 Vaccine, Adjuvanted, in healthy, HIV--1 uninfected adults
    A randomized, double-blinded, placebo-controlled, dose-escalation phase 1 clinical trial to evaluate the safety and immunogenicity of recombinant HIV envelope protein BG505 SOSIP.664 gp140 Vaccine, Adjuvanted, in healthy, HIV--1 uninfected adults   
Principal Investigator(s)
1. Omu Anzala
Site(s) in Kenya
KAVI-ICR KNH SITE
 
08-07-2019 View

382.

ECCT/19/02/01   DANCE Study
    An Open-Label, Single Arm Study to Evaluate the Week 48 Efficacy and Safety of a Two-Drug Regimen of Dolutegravir/Lamivudine (DTG/3TC) as a Fixed Dose Combination (FDC), in Antiretroviral Therapy (ART)-Naive HIV-1-Infected Adolescents, ≥12 To <18 Years of Age who Weigh at Least 40 Kg.   
Principal Investigator(s)
1. Fredrick Odhiambo Otieno
2. Isaac Tsikhutsu
Site(s) in Kenya
1. Nyanza Reproductive Health Society (Kisumu county)
2. Kenya Medical Research Institute (Kisumu county)
3. Kenya Medical Research Institute, Walter Reed Project (Kericho county)
 
14-08-2019 View

383.

ECCT/19/01/02   Opt4Kids
    Optimizing viral load suppression in Kenyan children on antiretroviral therapy (Opt4Kids)   
Principal Investigator(s)
1. Lisa Dillabaugh Abuogi
2. Patrick Oyaro Owiti
Site(s) in Kenya
1. Kisumu County Hospital (Kisumu county)
2. Ahero County Hospital (Kisumu county)
3. Nyakach County Hospital (Kisumu county)
4. Lumumba sub-County Hospital (Kisumu county)
5. Jaramogi Oginga Odinga Teaching and Referral Hospital (Kisumu county)
 
15-03-2019 View

384.

ECCT/19/01/01   A Randomized, Open, Parallel-group, Single Dose, Phase 2a Study, to Investigate the Clinical and Parasiticidal Activity and the Pharmacokinetics of 3 dose levels of Artefenomel in combination with Ferroquine (FQ) and FQ alone, in African Patients with Unc
    A Randomized, Open label, Parallel-group, Single Dose Regimen, Phase 2a Study, to Investigate the Clinical and Parasiticidal Activity and the Pharmacokinetics of 3 dose levels of Artefenomel (OZ439) given in combination with Ferroquine (FQ) and FQ alone, in African Patients with Uncomplicated Plasmodium falciparum Malaria   
Principal Investigator(s)
1. Bernhards Ogutu Ragama
Site(s) in Kenya
1. Ahero County hospital (Kisumu county)
2. Siaya County Hospital (Siaya county)
 
13-08-2019 View

385.

ECCT/18/12/02   Randomized Controlled Trial to Compare the Effect of Corn-Soy Blend + Vegetable Oil 8 and Fish Oil (CSB-VO-FO) With Corn-Soy Blend + Vegetable Oil Alone (CSB-VO) on 9 the Immunological and Microbiota Patterns among Children Aged 6 to 24 months with 10 Mod
    Randomized Controlled Trial to Compare the Effect of Corn-Soy Blend + Vegetable Oil 8 and Fish Oil (CSB-VO-FO) With Corn-Soy Blend + Vegetable Oil Alone (CSB-VO) on 9 the Immunological and Microbiota Patterns among Children Aged 6 to 24 months with 10 Mod   
Principal Investigator(s)
1. CHRISTOPHER L. MELBY MELBY
Site(s) in Kenya
KENYA MEDICAL RESEARCH INSTITUTE
 
25-02-2019 View

386.

ECCT/18/11/02   EPI 003
    A prospective study to evaluate the safety, effectiveness and impact of the RTS,S/AS01E vaccine in young children in sub-Saharan Africa.   
Principal Investigator(s)
1. BERNHARDS OGUTU
Site(s) in Kenya
1. • Ahero Clinical Trials Unit (Kisumu county)
2. KEMRI Walter Reed Army Institute of Research (Kisumu county)
3. KEMRI CDC SIAYA (Siaya county)
 
25-03-2019 View

387.

ECCT/18/11/01   PrIMA
              PrEP Implementation for Mothers in Antenatal Care            
Principal Investigator(s)
1. Grace John-Stewart John-Stewart
2. Jared Baeten
Site(s) in Kenya
1. Homa Bay County - 10 sites (Homa Bay county)
2. Siaya County - 10 sites (Siaya county)
 
16-05-2019 View

388.

ECCT/18/10/02   Single-dose HPV catch-up vaccination efficacy: A blinded, randomized study of single-dose HPV vaccination among adolescent girls and young women in Kenya
            Single-dose HPV catch-up vaccination efficacy: A blinded, randomized study of single-dose HPV vaccination among adolescent girls and young women in Kenya    
Principal Investigator(s)
1. Dr. Nelly Rwamba Mugo
2. Dr. Maricianah Atieno Onono
3. Prof Bukusi Anne Bukusi
4. Dr. Betty Wanjiru Njoroge
5. Dr. Ruanne Barnabas
Site(s) in Kenya
1. KEMRI NAIROBI (Nairobi City county)
2. KEMRI KISUMU (Kisumu county)
3. KEMRI THIKA PHRD (Kiambu county)
 
19-11-2018 View

389.

ECCT/18/12/01   study to determine if a new malaria vaccine is safe and induces immunity among Kenyan adults, young children and infants.
    A Phase 1b, open-label, age de-escalation, dose-escalation study to evaluate the safety and immunogenicity of different doses of a candidate malaria vaccine; adjuvanted R21(R21/MM) in adults, young children and infants in Kilifi, Kenya.   
Principal Investigator(s)
1. Mainga Hamaluba
Site(s) in Kenya
KEMRI-Wellcome Trust Research Programme (KWTRP) Centre for Geographic Medical Research - Coast (CGMRC), Kilifi, Kenya.
 
19-03-2019 View

390.

ECCT/18/10/03   UMBIFLOW
    Prevalence and outcomes of abnormal continuous wave Doppler flow indices in unselected obstetric populations in low- and middle-income countries: The Umbiflow International Study.   
Principal Investigator(s)
1. Prof Zahida Parveen Qureshi
Site(s) in Kenya
1. Mbagathi District Hospital (Nairobi City county)
2. St. Mary\'s Hospital (Nairobi City county)
3. Kenyatta National Hospital (Nairobi City county)
 
21-12-2018 View